Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 4Venous Thrombosis 2Venous Thromboembolism 2Pulmonary Embolism 2Thrombosis 1Prostatic Neoplasms 1Myeloproliferative Disorders 1Multiple Endocrine Neoplasia Type 1 1Hot Flashes 1Cushing Syndrome 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Advanced Non-small Cell Lung Cancer 1

Interventions

Dalteparin 7apixaban 6Rivaroxaban 3edoxaban 2bemiparin 2Warfarin 2Tinzaparin 2Fondaparinux 2Enoxaparin 2Dabigatran 2Phenprocoumon 1Nephrectomy 1Nadroparin 1Heparin, Low-Molecular-Weight 1Heparin 1Aspirin 1Acetylcysteine 1Acenocoumarol 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Pulmonary Embolism × Dabigatran × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01727427 2019-08-08

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

G. d'Annunzio University

Completed
695 enrolled

Neoplasms, Pulmonary Embolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡